-
Mashup Score: 0The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass - PubMed - 1 year(s) ago
Since February 1, 1980, the identical standardized Greenville Gastric Bypass has been performed in 397 morbidly obese patients with an operative mortality rate of 0.8%. The operation effectively controlled weight and maintained satisfactory weight loss even after 6 years (mean weights and ranges: Pr …
Source: PubMedCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 226
Comparison of intermittent fasting plus early time-restricted eating (iTRE) to calorie restriction, as well as standard care, in adults at risk of type 2 diabetes in a three-arm randomized controlled study demonstrated that iTRE was associated with greater improvements in postprandial glucose metabolism at 6 months.
Source: NatureCategories: Expert Picks, Latest HeadlinesTweet-
A randomized trial of time-restricted eating (w/ intermittent fasting, iTRE) vs calorie restriction or standard care in people at risk for diabetes #T2DM https://t.co/BuyDdOYdJb iTRE best for glucose metabolism @NatureMedicine https://t.co/AoHi0Z0b0K
-
-
Mashup Score: 0Associations of the built environment with type 2 diabetes in Asia: a systematic review - 1 year(s) ago
Objectives Our study aimed to systematically review the literature and synthesise findings on potential associations of built environment characteristics with type 2 diabetes (T2D) in Asia. Design Systematic review of the literature. Data sources Online databases Medline, Embase and Global Health were used to identify peer-reviewed journal articles published from inception to 23 January…
Source: BMJ OpenCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Associations of the built environment with type 2 #diabetes #T2DM in Asia: a systematic review https://t.co/8wKZjCjPR1
-
-
Mashup Score: 9
Nature Reviews Endocrinology – Sulfonylurea secondary failure mechanism identified
Source: NatureCategories: Endocrinology, Latest HeadlinesTweet-
AOP #ResearchHighlight: a new study investigates the mechanisms underlying the secondary failure of #sulfonylureas (£) https://t.co/3MeWMWV3A5 #diabetes #T2DM #T2D https://t.co/p1bDNduzfg
-
-
Mashup Score: 5
Empagliflozin provided clinically relevant placebo-corrected reductions in HbA1c, whereas linagliptin did not, and might offer a new treatment option for young people with type 2 diabetes.
Categories: Cardiologists, Latest HeadlinesTweet-
Efficacy and safety of the #SGLT2i #empagliflozin Vs placebo and the #DPP4i #linagliptin Vs placebo in young people with #T2DM (#DINAMO): a multicentre, randomized, double-blind, parallel group, phase 3 trial https://t.co/g9X0AH4jjY @TheLancetEndo #CardioTwitter https://t.co/vqJavd9Yn1
-
-
Mashup Score: 1Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice - Nature Reviews Endocrinology - 1 year(s) ago
Cardiorenal diseases are common in patients with type 2 diabetes mellitus (T2DM), with substantial morbidity and premature mortality. This Review discusses how atherosclerotic cardiovascular disease and cardiorenal diseases can be prevented in T2DM, considering evidence from clinical trials and its implementation in clinical practice.
Source: NatureCategories: Endocrinology, Latest HeadlinesTweet-
From our latest issue: Lee-Ling Lim, Elaine Chow & Juliana C. N. Chan discuss #cardiorenal diseases in type 2 #diabetes mellitus (£) https://t.co/IlLRqGwpYG #T2D #T2DM https://t.co/62rABNEByJ
-
-
Mashup Score: 2EVOLUTION HF Study Finds Novel GDMTs Are Often Delayed For HF - American College of Cardiology - 1 year(s) ago
Initiation of novel guideline-directed medical therapies (GDMTs) for patients with heart failure (HF) is delayed compared with other GDMTs, and few patients received target doses of GDMTs requiring uptitration, according to an article published Oct. 12 in JACC: Heart Failure. Gianluigi Savarese, MD, et al., conducted a multinational, observational cohort study using routine-care databases to…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
From #JACCHF: Initiation of novel guideline-directed medical therapies for patients with #heartfailure is delayed compared with other GDMTs & few patients received target doses of GDMTs requiring uptitration. More on the EVOLUTION HF study: https://t.co/2TecZYQDN1 #T2DM
-
-
Mashup Score: 9Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV - 1 year(s) ago
AbstractContext. VERTIS CV evaluated the cardiovascular safety of ertugliflozin in patients with type 2 diabetes and atherosclerotic cardiovascular disease (ASC
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
#Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in #T2DM Patients These Analyses From #VERTIS CV show that ertugliflozin can reduce the need for insulin therapy in both insulin-naïve and insulin-treated patients #SGLT2i https://t.co/KXVLowKNHn https://t.co/4GhZGq7o4l
-
-
Mashup Score: 1Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Despite studies demonstrating an inverse & independent association between CRF & various cardiometabolic outcomes, the % of age-predicted CRF & risk of #T2DM has not been investigated. Dr. Kunutsor et al. examine this relationship here: https://t.co/NQEmsWrqTr https://t.co/qrWrFK4TQV
-
-
Mashup Score: 0Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis - 1 year(s) ago
AbstractAims. Finerenone reduces the risk of cardiovascular events in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). We investigated the
Source: OUP AcademicCategories: Cardiology News and Journals, Latest HeadlinesTweet-
FIDELITY trial: #Finerenone significantly reduced the risk of all-cause and CV mortality in #T2DM patients across a broad spectrum of #CKD stages, as well as sudden cardiac death https://t.co/u06NNP1YXn @Filippatos @JJheart_doc #kidneydisease #EHJPharmacotherapy @AgewallStefan https://t.co/smuIAuJ8wT
-
The first paper by Walter Pories discussed the findings of the Greenville Gastric Bypass and how it could remit type 2 diabetes - #T2DM #DM #diabetes #obesity #bariatricsurgery 5/ The control of diabetes mellitus withe the Greenville Gastric Bypass - https://t.co/YWjY406B9z